Showing results (1-10 of 3,237) with videos related to
Sort By:
Pageof 324
American Heart Journal|May 1, 1986
The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmiaG Hirsowitz, P J Podrid, S Lampert, et al.American Heart Journal|May 1, 1984
Long-term mexiletine for ventricular arrhythmiaJ Stein, P J Podrid, S Lampert, et al.Journal of the American College of Cardiology|February 1, 1986
Mexiletine and tocainide: does response to one predict response to the other?M Hession, R Blum, P J Podrid, et al.Journal of the American College of Cardiology|November 1, 1989
Congestive heart failure induced by six of the newer antiarrhythmic drugsS Ravid, P J Podrid, S Lampert, et al.The American Journal of Cardiology|February 1, 1988
Clinical predictors of arrhythmia worsening by antiarrhythmic drugsW Slater, S Lampert, P J Podrid, et al.The American Journal of Cardiology|October 16, 1987
Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmiasM J Hession, S Lampert, P J Podrid, et al.The American Journal of Cardiology|October 16, 1987
Considerations of current methods for drug selection in treating malignant ventricular arrhythmiasB Lown, P J Podrid, T B Graboys, et al.The American Journal of Cardiology|April 1, 1988
Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery diseaseS Lampert, B Lown, T B Graboys, et al.The American Journal of Cardiology|April 30, 1987
Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictorsP J Podrid, S Lampert, T B Graboys, et al.Journal of the American College of Cardiology|July 1, 1984
Propafenone: a new agent for ventricular arrhythmiaP J Podrid, B LownPageof 324